Mestag Therapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Suite 15 Science Village Chesterford Res...Website
www.mestagtherapeutics.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Mestag Therapeutics
Mestag Therapeutics is a UKbased biotechnology company focused on discovering and developing novel antibodybased medicines for cancer and inflammatory diseases. It uses advanced insights into fibroblastimmune interactions and a proprietary target discovery platform to create firstinclass therapies that aim to harness the immune system and address unmet medical needs in solid tumors and chronic inflammatory conditions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mestag Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mestag Therapeutics has new funding data
Click to see if Mestag Therapeutics had a recent Job posting/layoffs
Check if Mestag Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Mestag Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mestag Therapeutics
Check out if Mestag Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Mestag Therapeutics recently announced quarterly report
Product Launch: Get notified when Mestag Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Mestag Therapeutics
Compare insights from companies similar to Mestag Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mestag Therapeutics
$10.6M
11-50
Private
$41.9M
2020
N/A
Company Profile Activity
Activity Insights
Mestag Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mestag Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mestag Therapeutics.
Mestag Therapeutics financials insights
Gather financial insights about Mestag Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$1.9M
2026
Unspecified
$40M
Mestag Therapeutics Tech Stack
A closer look at the technologies used by Mestag Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Promotion
Executive Move
Executive Moves, Promotion
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Mestag Therapeutics News & Media
Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting
Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual MeetingMestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic
Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the ClinicMestag Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia
CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and cancer, announced today that it will be presenting a poster at the Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations Keystone Symposia taking place March 15-18, 2026, in Québec City, Canada, titled “MST-0312: FAP-targeted LTBR Agonist Induces High Endothelial VMestag Therapeutics appoints new chief scientific officer - Bdaily
Bdaily UK | Business News
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Mestag Therapeutics
Sign Up For FreeTo access detailed company insights
Mestag Therapeutics is a UKbased biotechnology company focused on discovering and developing novel antibodybased medicines for cancer and inflammatory diseases. It uses advanced insights into fibroblastimmune interactions and a proprietary target discovery platform to create firstinclass therapies that aim to harness the immune system and address u... Read More
